Letter to the editor.
Pomper
Martin G
MG
D001086:Arabinofuranosyluracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D001424:Bacterial Infections / Q000175:diagnosis*; D002986:Clinical Trials as Topic; D003952:Diagnostic Imaging / Q000379:methods*; D006801:Humans; D017093:Liver Failure / Q000209:etiology*
D001086:Arabinofuranosyluracil; C043457:fialuridine